Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 2055 results found since Jan 2013.

Herpes Zoster Virus: Should Patients With Chronic Respiratory Diseases Be Vaccinated?
Arch Bronconeumol. 2023 Jul 14:S0300-2896(23)00227-2. doi: 10.1016/j.arbres.2023.07.012. Online ahead of print.NO ABSTRACTPMID:37517934 | DOI:10.1016/j.arbres.2023.07.012
Source: Archivos de Bronconeumologia - July 30, 2023 Category: Respiratory Medicine Authors: Rosario Men éndez Paula Gonz ález-Jiménez Ra úl Méndez Source Type: research

Use of Information and Communication Technology Strategies to Increase Vaccination Coverage in Older Adults: A Systematic Review
CONCLUSIONS: Prevention programs using ICT tools could be effective in promoting immunizations among older adults.PMID:37515089 | DOI:10.3390/vaccines11071274
Source: Herpes - July 29, 2023 Category: Infectious Diseases Authors: Alessandra Buja Giulia Grotto Mustapha Taha Silvia Cocchio Vincenzo Baldo Source Type: research

Measles and Varicella Vaccination Program in a Hospital: Implementation and Impact on Contact Tracing
This study aims to describe the implementation process of a measles and varicella vaccination program and report on the reduction in the number of susceptible healthcare workers exposed to measles, varicella, and disseminated herpes zoster at a tertiary hospital. The Consolidated Framework for Implementation Research (CFIR) model was used to describe the vaccination program implemented from October 2015 to September 2018. The number of exposed, reviewed, and susceptible healthcare workers during contact tracing for exposure to (a) measles and (b) varicella and disseminated herpes zoster in 2016, 2017, and 2018 is reported....
Source: Herpes - July 29, 2023 Category: Infectious Diseases Authors: Alicia Siew Ting Loi Revathi Sridhar See Ming Lim Source Type: research

Use of Information and Communication Technology Strategies to Increase Vaccination Coverage in Older Adults: A Systematic Review
CONCLUSIONS: Prevention programs using ICT tools could be effective in promoting immunizations among older adults.PMID:37515089 | PMC:PMC10384530 | DOI:10.3390/vaccines11071274
Source: Herpes - July 29, 2023 Category: Infectious Diseases Authors: Alessandra Buja Giulia Grotto Mustapha Taha Silvia Cocchio Vincenzo Baldo Source Type: research

Measles and Varicella Vaccination Program in a Hospital: Implementation and Impact on Contact Tracing
This study aims to describe the implementation process of a measles and varicella vaccination program and report on the reduction in the number of susceptible healthcare workers exposed to measles, varicella, and disseminated herpes zoster at a tertiary hospital. The Consolidated Framework for Implementation Research (CFIR) model was used to describe the vaccination program implemented from October 2015 to September 2018. The number of exposed, reviewed, and susceptible healthcare workers during contact tracing for exposure to (a) measles and (b) varicella and disseminated herpes zoster in 2016, 2017, and 2018 is reported....
Source: Herpes - July 29, 2023 Category: Infectious Diseases Authors: Alicia Siew Ting Loi Revathi Sridhar See Ming Lim Source Type: research

Cladribine tablets for highly active relapsing-remitting multiple sclerosis in Poland: a real-world, multi-centre, retrospective, cohort study during the COVID-19 pandemic
CONCLUSIONS: Cladribine tablets proved safe and effective in a real-world cohort of treatment-experienced patients. However, the efficacy measures improved to a lesser extent in our cohort than in the pivotal clinical trial, which is probably due to a higher proportion of treatment-experienced patients in our cohort.PMID:37490356 | DOI:10.5603/PJNNS.a2023.0050
Source: Neurologia i Neurochirurgia Polska - July 25, 2023 Category: Neurology Authors: Adam St ępień Aleksandra Pogoda-Weso łowska El żbieta Tokarz-Kupczyk Agnieszka S łowik Przemys ław Puz Monika Adamczyk-Sowa Iwona Kurkowska-Jastrz ębska Alina Ku łakowska Monika Chor ąży Karolina Piasecka-Stryczy ńska Anna Jamr óz-Wiśniewska Source Type: research

Effect of the varicella vaccination on the clinical characteristics of herpes zoster cases aged 20 years and under
In conclusion, the number and spread of shingles in most children and adolescents are less, and the complications such as PHN are less. Varicella vaccination can reduce the decrustation time and relieve shingles cases with some clinical symptoms.PMID:37482741 | DOI:10.3760/cma.j.cn112150-20220905-00868
Source: Herpes - July 24, 2023 Category: Infectious Diseases Authors: M Y You W Jiang Y H Hu M M Wang T Q Wang X D Li Y Yan D P Yin Source Type: research

Herpes zoster vaccine safety in the Aotearoa  New Zealand population: a self-controlled case series study
This study assessed the risk of pre-specified serious adverse events following zoster vaccine live immunisation among adults in routine clinical practice. We conducted a self-controlled case series study using routinely collected national data. We compared the incidence of serious adverse events during the at-risk period with the control period. Rate ratios were estimated using Conditional Poisson regression models. Falsification outcomes analyses were used to evaluate biases in our study population. From April 2018 to July 2021, 278,375 received the vaccine. The rate ratio of serious adverse events following immunisation ...
Source: Herpes - July 19, 2023 Category: Infectious Diseases Authors: James F Mbinta Alex X Wang Binh P Nguyen Janine Paynter Prosper Mandela A Awuni Russell Pine Andrew A Sporle Steve Bowe Colin R Simpson Source Type: research

The Association between Varicella Vaccination and Herpes Zoster in Children: A Semi-National Retrospective Study
J Clin Med. 2023 Jun 27;12(13):4294. doi: 10.3390/jcm12134294.ABSTRACTVaricella vaccination in children has been performed worldwide in recent years. Despite established effectiveness, many countries still do not routinely vaccinate children against varicella, probably due to concerns about complications, such as herpes zoster infection. We aimed to compare the herpes zoster incidence in children before and after implementing the mandatory varicella vaccine in Israel in 2008. As a secondary aim, we characterized several parameters, including age, sex, and ethnic sector among herpes zoster cases, and we evaluated the compli...
Source: Herpes - July 14, 2023 Category: Infectious Diseases Authors: Ester Forer Adi Yariv Daniel Ostrovsky Amir Horev Source Type: research

Lower risk for COVID-19 hospitalization among patients in the United States with past vaccinations for herpes zoster and tetanus, diphtheria and pertussis
Prev Med Rep. 2023 Jun 25;35:102302. doi: 10.1016/j.pmedr.2023.102302. eCollection 2023 Oct.ABSTRACTInfluenza, tetanus, diphtheria, and herpes zoster (HZ) vaccination received within 10 years of the COVID-19 pandemic have been associated with less severe COVID-19 infection. We expanded on this evidence to determine if a receiving two different vaccinations (i.e., HZ and tetanus, diphtheria, and pertussis (Tdap)) was associated with a lower risk for COVID-19 hospitalization. De-identified medical record data from a large mid-western health care system was used to determine if, compared to those with neither HZ or Tdap vacci...
Source: Herpes - July 13, 2023 Category: Infectious Diseases Authors: Joanne Salas John E Morley Daniel F Hoft Jeffrey F Scherrer Source Type: research

Prevention of Shingles in Dermatology Patients on Systemic Medications
Skin Therapy Lett. 2023 Jul;28(4):4-6.ABSTRACTThe lifetime risk for herpes zoster (HZ) of approximately 1 in 3 is increased with advancing age, a family history of HZ, diseases with altered immune function, immunosuppression, physical trauma and psychological stress. In dermatology, monotherapy with current biologics does not increase risk, however systemic steroids, Janus kinase inhibitors and combination biologic/conventional disease-modifying antirheumatics do. The recombinant zoster vaccine (RZV, Shingrix®), an adjuvanted non-live subunit vaccine against the glycoprotein E subunit of varicella zoster virus, is approve...
Source: Skin Therapy Letter - July 13, 2023 Category: Dermatology Authors: Lyn Guenther Source Type: research